These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 18309574)

  • 1. Development of a rapid and sensitive LC-MS/MS assay for the determination of sorafenib in human plasma.
    Jain L; Gardner ER; Venitz J; Dahut W; Figg WD
    J Pharm Biomed Anal; 2008 Jan; 46(2):362-7. PubMed ID: 18309574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rapid and sensitive method for determination of sorafenib in human plasma using a liquid chromatography/tandem mass spectrometry assay.
    Zhao M; Rudek MA; He P; Hafner FT; Radtke M; Wright JJ; Smith BD; Messersmith WA; Hidalgo M; Baker SD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 846(1-2):1-7. PubMed ID: 16798122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Simultaneous determination of donafenib and its N-oxide metabolite in human plasma by liquid chromatography-tandem mass spectrometry].
    Wang J; Lü BH; Dai XJ; Zhang YF; Chen XY; Zhong DF
    Yao Xue Xue Bao; 2017 Mar; 52(3):443-8. PubMed ID: 29979858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitation of sorafenib and its active metabolite sorafenib N-oxide in human plasma by liquid chromatography-tandem mass spectrometry.
    Li L; Zhao M; Navid F; Pratz K; Smith BD; Rudek MA; Baker SD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Nov; 878(29):3033-8. PubMed ID: 20870468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new rapid and sensitive LC-MS assay for the determination of sorafenib in plasma: application to a patient undergoing hemodialysis.
    Bobin-Dubigeon C; Heurgue-Berlot A; Bouché O; Amiand MB; Le Guellec C; Bard JM
    Ther Drug Monit; 2011 Dec; 33(6):705-10. PubMed ID: 22105587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous analysis of regorafenib and sorafenib and three of their metabolites in human plasma using LC-MS/MS.
    Allard M; Khoudour N; Rousseau B; Joly C; Costentin C; Blanchet B; Tournigand C; Hulin A
    J Pharm Biomed Anal; 2017 Aug; 142():42-48. PubMed ID: 28494338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of 2-methoxyestradiol in human plasma, using liquid chromatography/tandem mass spectrometry.
    Lakhani NJ; Lepper ER; Sparreboom A; Dahut WL; Venitz J; Figg WD
    Rapid Commun Mass Spectrom; 2005; 19(9):1176-82. PubMed ID: 15818726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Drug Monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometry.
    Haouala A; Zanolari B; Rochat B; Montemurro M; Zaman K; Duchosal MA; Ris HB; Leyvraz S; Widmer N; Decosterd LA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jul; 877(22):1982-96. PubMed ID: 19505856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liquid chromatography-tandem mass spectrometric assay for the multikinase inhibitor regorafenib in plasma.
    Luethi D; Durmus S; Schinkel AH; Schellens JH; Beijnen JH; Sparidans RW
    Biomed Chromatogr; 2014 Oct; 28(10):1366-70. PubMed ID: 24619951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simple and selective method for the determination of various tyrosine kinase inhibitors used in the clinical setting by liquid chromatography tandem mass spectrometry.
    Honeywell R; Yarzadah K; Giovannetti E; Losekoot N; Smit EF; Walraven M; Lind JS; Tibaldi C; Verheul HM; Peters GJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 May; 878(15-16):1059-68. PubMed ID: 20382575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous analysis of anticancer agents bortezomib, imatinib, nilotinib, dasatinib, erlotinib, lapatinib, sorafenib, sunitinib and vandetanib in human plasma using LC/MS/MS.
    Andriamanana I; Gana I; Duretz B; Hulin A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 926():83-91. PubMed ID: 23562906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A liquid chromatography/tandem mass spectrometry assay to quantitate MS-275 in human plasma.
    Zhao M; Rudek MA; Mnasakanyan A; Hartke C; Pili R; Baker SD
    J Pharm Biomed Anal; 2007 Jan; 43(2):784-7. PubMed ID: 16971082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a sensitive liquid chromatography tandem mass spectrometry assay for the simultaneous determination of ten kinase inhibitors in human serum and plasma.
    Aghai F; Zimmermann S; Kurlbaum M; Jung P; Pelzer T; Klinker H; Isberner N; Scherf-Clavel O
    Anal Bioanal Chem; 2021 Jan; 413(2):599-612. PubMed ID: 33155133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liquid chromatography-tandem mass spectrometric assay for sorafenib and sorafenib-glucuronide in mouse plasma and liver homogenate and identification of the glucuronide metabolite.
    Sparidans RW; Vlaming ML; Lagas JS; Schinkel AH; Schellens JH; Beijnen JH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jan; 877(3):269-76. PubMed ID: 19117812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A highly efficient and sensitive LC-MS/MS method for the determination of afatinib in human plasma: application to a metabolic stability study.
    Kadi AA; Abdelhameed AS; Darwish HW; Attwa MW; Al-Shakliah NS
    Biomed Chromatogr; 2016 Aug; 30(8):1248-55. PubMed ID: 26683307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a UPLC-MS/MS method for determination of motesanib in plasma: Application to metabolic stability and pharmacokinetic studies in rats.
    Ezzeldin E; Iqbal M; Al-Salahi R; El-Nahhas T
    J Pharm Biomed Anal; 2019 Mar; 166():244-251. PubMed ID: 30665192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous determination of rosuvastatin and fenofibric acid in human plasma by LC-MS/MS with electrospray ionization: assay development, validation and application to a clinical study.
    Trivedi RK; Kallem RR; Mullangi R; Srinivas NR
    J Pharm Biomed Anal; 2005 Sep; 39(3-4):661-9. PubMed ID: 15970417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of PF-04928473 in human plasma using liquid chromatography with tandem mass spectrometry.
    Jain L; Gardner ER; Venitz J; Giaccone G; Houk BE; Figg WD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Nov; 878(30):3187-92. PubMed ID: 20951100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of serum amantadine by liquid chromatography-tandem mass spectrometry.
    Arndt T; Guessregen B; Hohl A; Reis J
    Clin Chim Acta; 2005 Sep; 359(1-2):125-31. PubMed ID: 15913590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a highly sensitive and robust LC-MS/MS with electrospray ionization method for quantification of rosuvastatin in small volume human plasma samples and its application to a clinical study.
    Kallem RR; Karthik A; Chakradhar L; Mullangi R; Srinivas NR
    Arzneimittelforschung; 2007; 57(11):705-11. PubMed ID: 18193692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.